Electromed (ELMD)
(Real Time Quote from BATS)
$16.47 USD
+0.21 (1.29%)
Updated May 23, 2024 03:46 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Electromed, Inc. [ELMD]
Reports for Purchase
Showing records 21 - 40 ( 46 total )
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
ELMD Q3 12 revenue and net below expectations, lowering estimates and target price
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
ELMD Q2 12 revenue and net basically in line with our revised expectations
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Q2 12 Preannounces revenue and EPS shortfall, reducing target price to $5
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Electromed, Inc.
Industry: Medical - Instruments
ELMD Q1 12 revenue and net income modestly above our expectations, EPS in line
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Q1 11 preview - expect strong top line growth, but CFO transition hurts EPS
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Electromed, Inc.
Industry: Medical - Instruments
Q4 11 strong top line growth translates into 70% increase in operating income
Provider: FELTL & COMPANY
Analyst: ANDBERG E
Company: Electromed, Inc.
Industry: Medical - Instruments
Company: Electromed, Inc.
Industry: Medical - Instruments
Q3 11 breathing easier-results beat our estimates, raising estimates and target price
Provider: FELTL & COMPANY
Analyst: ANDBERG E